Hisamitsu Pharmaceutical Co., Inc. HPX.F Stock
Hisamitsu Pharmaceutical Co., Inc. Price Chart
Hisamitsu Pharmaceutical Co., Inc. HPX.F Financial and Trading Overview
| Hisamitsu Pharmaceutical Co., Inc. stock price | 21 EUR |
| Previous Close | 23.2 EUR |
| Open | 22.6 EUR |
| Bid | 23 EUR x 40000 |
| Ask | 24.2 EUR x 40000 |
| Day's Range | 22.6 - 22.6 EUR |
| 52 Week Range | 22.4 - 27.8 EUR |
| Volume | 174 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.8B EUR |
| Beta (5Y Monthly) | 0.557088 |
| PE Ratio (TTM) | 23.061224 |
| EPS (TTM) | 1.06 EUR |
| Forward Dividend & Yield | 0.58 (2.48%) |
| Ex-Dividend Date | August 30, 2023 |
| 1y Target Est | N/A |
HPX.F Valuation Measures
| Enterprise Value | -130727329792 EUR |
| Trailing P/E | 23.061224 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.014054583 |
| Price/Book (mrq) | 0.0068536233 |
| Enterprise Value/Revenue | -1.019 |
| Enterprise Value/EBITDA | -7.898 |
Trading Information
Hisamitsu Pharmaceutical Co., Inc. Stock Price History
| Beta (5Y Monthly) | 0.557088 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 27.8 EUR |
| 52 Week Low | 22.4 EUR |
| 50-Day Moving Average | 24.58 EUR |
| 200-Day Moving Average | 25.1 EUR |
HPX.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 78.1M |
| Float | 57.07M |
| Short Ratio | N/A |
| % Held by Insiders | 26.45% |
| % Held by Institutions | 35.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 84 |
| Trailing Annual Dividend Yield | 362.06% |
| 5 Year Average Dividend Yield | 183.00% |
| Payout Ratio | 0.568 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2023 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | February 28, 2024 |
Profitability
| Profit Margin | 9.15% |
| Operating Margin (ttm) | 9.03% |
| Gross Margin | 56.65% |
| EBITDA Margin | 12.89% |
Management Effectiveness
| Return on Assets (ttm) | 2.35% |
| Return on Equity (ttm) | 4.72% |
Income Statement
| Revenue (ttm) | 128.33B EUR |
| Revenue Per Share (ttm) | 1617.47 EUR |
| Quarterly Revenue Growth (yoy) | 8.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | 16.55B EUR |
| Net Income Avi to Common (ttm) | 11.74B EUR |
| Diluted EPS (ttm) | 0.98 |
| Quarterly Earnings Growth (yoy) | -35.50% |
Balance Sheet
| Total Cash (mrq) | 136.87B EUR |
| Total Cash Per Share (mrq) | 1760.49 EUR |
| Total Debt (mrq) | 2.3B EUR |
| Total Debt/Equity (mrq) | 0.89 EUR |
| Current Ratio (mrq) | 4.678 |
| Book Value Per Share (mrq) | 3297.526 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 12.73B EUR |
| Levered Free Cash Flow (ttm) | 10.12B EUR |
Profile of Hisamitsu Pharmaceutical Co., Inc.
| Country | Germany |
| State | N/A |
| City | Tosu |
| Address | 408, Tashiro Daikan-machi |
| ZIP | 841-0017 |
| Phone | 81 3 5293 1720 |
| Website | https://www.hisamitsu.co.jp |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2769 |
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Q&A For Hisamitsu Pharmaceutical Co., Inc. Stock
What is a current HPX.F stock price?
Hisamitsu Pharmaceutical Co., Inc. HPX.F stock price today per share is 21 EUR.
How to purchase Hisamitsu Pharmaceutical Co., Inc. stock?
You can buy HPX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hisamitsu Pharmaceutical Co., Inc.?
The stock symbol or ticker of Hisamitsu Pharmaceutical Co., Inc. is HPX.F.
Which industry does the Hisamitsu Pharmaceutical Co., Inc. company belong to?
The Hisamitsu Pharmaceutical Co., Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hisamitsu Pharmaceutical Co., Inc. have in circulation?
The max supply of Hisamitsu Pharmaceutical Co., Inc. shares is 77.69M.
What is Hisamitsu Pharmaceutical Co., Inc. Price to Earnings Ratio (PE Ratio)?
Hisamitsu Pharmaceutical Co., Inc. PE Ratio is 19.81132100 now.
What was Hisamitsu Pharmaceutical Co., Inc. earnings per share over the trailing 12 months (TTM)?
Hisamitsu Pharmaceutical Co., Inc. EPS is 1.06 EUR over the trailing 12 months.
Which sector does the Hisamitsu Pharmaceutical Co., Inc. company belong to?
The Hisamitsu Pharmaceutical Co., Inc. sector is Healthcare.